Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,669 | 912 | 99.7% |
| Education | $42.39 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,120 | 151 | $0 (2024) |
| PFIZER INC. | $1,638 | 107 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,091 | 96 | $0 (2023) |
| Allergan, Inc. | $1,034 | 101 | $0 (2020) |
| GlaxoSmithKline, LLC. | $846.16 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $756.22 | 36 | $0 (2024) |
| Novo Nordisk Inc | $752.50 | 72 | $0 (2024) |
| Amgen Inc. | $523.51 | 30 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $463.36 | 41 | $0 (2023) |
| Lilly USA, LLC | $438.98 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,308 | 81 | ABBVIE INC. ($556.62) |
| 2023 | $1,147 | 67 | AbbVie Inc. ($483.41) |
| 2022 | $1,074 | 57 | ABBVIE INC. ($475.68) |
| 2021 | $2,027 | 144 | AbbVie Inc. ($604.72) |
| 2020 | $2,032 | 139 | Allergan, Inc. ($330.38) |
| 2019 | $1,417 | 117 | Allergan Inc. ($239.89) |
| 2018 | $1,542 | 139 | Novo Nordisk Inc ($248.21) |
| 2017 | $2,166 | 173 | Novo Nordisk Inc ($276.51) |
All Payment Transactions
917 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Insomnia | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: VIROLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: PAIN | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,254 | 2,744 | $249,232 | $135,414 |
| 2022 | 12 | 1,018 | 3,135 | $194,470 | $134,650 |
| 2021 | 14 | 1,304 | 3,908 | $234,955 | $174,715 |
| 2020 | 15 | 1,571 | 3,792 | $263,666 | $178,126 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 441 | 1,577 | $104,151 | $57,609 | 55.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 235 | 235 | $37,969 | $30,999 | 81.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 253 | 420 | $62,345 | $29,516 | 47.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 44 | 44 | $11,485 | $4,695 | 40.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 71 | 95 | $7,805 | $2,879 | 36.9% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 43 | $5,160 | $2,319 | 44.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 49 | 56 | $5,311 | $2,101 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $3,882 | $1,661 | 42.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 21 | 36 | $2,788 | $1,225 | 44.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 16 | 16 | $2,252 | $955.68 | 42.4% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 27 | 31 | $2,982 | $732.84 | 24.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 31 | 36 | $913.98 | $410.04 | 44.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 27 | $920.00 | $238.38 | 25.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 112 | $1,267 | $72.77 | 5.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 495 | 2,401 | $131,580 | $87,797 | 66.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 200 | 200 | $27,035 | $26,433 | 97.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 98 | $8,792 | $6,315 | 71.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 85 | 116 | $8,020 | $3,742 | 46.7% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 19 | 42 | $4,410 | $2,706 | 61.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 44 | 58 | $4,665 | $2,480 | 53.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 21 | 21 | $3,087 | $2,234 | 72.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $1,315 | $1,051 | 79.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,319 | $925.65 | 39.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $1,027 | $502.76 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 39 | $960.00 | $361.80 | 37.7% |
About Dr. Stephen Datu, MD
Dr. Stephen Datu, MD is a Internal Medicine healthcare provider based in Red Bluff, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386746287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Datu, MD has received a total of $12,712 in payments from pharmaceutical and medical device companies, with $1,308 received in 2024. These payments were reported across 917 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($12,669).
As a Medicare-enrolled provider, Datu has provided services to 5,147 Medicare beneficiaries, totaling 13,579 services with total Medicare billing of $622,904. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Specialist
- Location Red Bluff, CA
- Active Since 09/01/2006
- Last Updated 02/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386746287
Products in Payments
- UBRELVY (Drug) $1,347
- VRAYLAR (Drug) $1,112
- XARELTO (Drug) $955.21
- ELIQUIS (Drug) $600.94
- TRELEGY ELLIPTA (Drug) $493.57
- Victoza (Drug) $442.76
- JARDIANCE (Drug) $415.83
- Livalo (Drug) $393.47
- LYRICA (Drug) $335.38
- CHANTIX (Drug) $298.76
- Otezla (Drug) $291.77
- QULIPTA (Drug) $287.27
- NURTEC ODT (Drug) $261.48
- Ozempic (Drug) $249.89
- XIFAXAN (Drug) $240.09
- LINZESS (Drug) $236.91
- FARXIGA (Drug) $224.57
- JANUVIA (Drug) $187.40
- LOKELMA (Drug) $187.10
- Aimovig (Biological) $182.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Red Bluff
Dr. Neil Louwrens, M.d, M.D
Internal Medicine — Payments: $3,150
Kerry Waits, D.o, D.O
Internal Medicine — Payments: $2,398
Giang Bui
Internal Medicine — Payments: $1,069
Dr. Jaimal Johal, Md, MD
Internal Medicine — Payments: $254.53
Richard Wickenheiser, Md, MD
Internal Medicine — Payments: $188.44
David Dahnke
Internal Medicine — Payments: $140.67